Published • loading... • Updated
K'taka FDA Seizes Spurious Drugs Worth ₹4.91 Crore
- On Tuesday, The Enforcement Wing of The Karnataka Food Safety and Drug Administration Department raided an unlicensed unit near Hejjala, Bidadi, uncovering an alleged racket involving the repackaging and relabelling of spurious medicines.
- Health Minister Khader told The Hindu the value of the seized drugs is estimated at around ₹5 crore, noting the facility operated without a valid manufacturing licence.
- Concerns over counterfeit medicines entering the pharmaceutical supply chain prompted further investigation by the FSDA to identify the source of these drugs and prevent potential risks.
- Intensified inspections across food and drug establishments, including Pharmacies, reflect the FSDA's broader enforcement strategy to strengthen surveillance across the pharmaceutical supply chain.
- To improve compliance, the State now requires Pharmacies and restaurants to display QR codes for consumer reporting of safety violations, complementing ongoing inspections from roadside eateries to government-run Indira Canteens.
Insights by Ground AI
12 Articles
12 Articles
K'taka FDA seizes spurious drugs worth ₹4.91 crore
·New Delhi, India
Read Full Article
Bengaluru FDA busts spurious drug racket, seizes stock worth Rs 5 crore
Spurious drugs valued at over Rs 5 crore were seized in Bengaluru. The drug wing of the FDA conducted a major operation near the Bidadi toll gate. Officials uncovered a racket repacking and relabeling drugs without a license. This seizure follows recent enforcement drives by the FDA across the city. Earlier inspections led to the sealing of a Zepto warehouse and an Indira Canteen kitchen.
·India
Read Full ArticleCoverage Details
Total News Sources12
Leaning Left2Leaning Right3Center1Last UpdatedBias Distribution50% Right
Bias Distribution
- 50% of the sources lean Right
50% Right
L 33%
C 17%
R 50%
Factuality
To view factuality data please Upgrade to Premium
